APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals (Q46821339)

25 December 2017

title

APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals (English)

1 reference

25 December 2017

0 references

1 reference

Simone C Sorkin

1

1 reference

25 December 2017

Francisco J Forestiero

2

1 reference

25 December 2017

Mario H Hirata

3

1 reference

25 December 2017

Elizabeth C R Guzmán

4

1 reference

25 December 2017

Selma A Cavalli

5

1 reference

25 December 2017

Marcelo C Bertolami

6

1 reference

25 December 2017

Luis A Salazar

7

1 reference

25 December 2017

Rosario D C Hirata

8

1 reference

25 December 2017

publication date

1 January 2005

1 reference

25 December 2017

Clinical Chemistry and Laboratory Medicine

published in

1 reference

25 December 2017

volume

43

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

1339-1345

1 reference

25 December 2017

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

The apoAI-CIII-AIV gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Role of genetic factors (CETP gene Taq I B polymorphism and Apo A-I gene Msp I polymorphism) in serum HDL-C levels in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Phenotypes, genotypes and response to statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

HDL: the metabolism, function, and therapeutic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Structure and function of apolipoprotein A-I and high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Gender-specific effects of estrogen receptor alpha gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

G-->A substitution at position -75 of the apolipoprotein A-I gene promoter. Evidence against a direct effect on HDL cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Clinical Pharmacokinetics of Atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

Atheroprotective mechanisms of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.229

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.229

1 reference

25 December 2017

1 reference

25 December 2017